All News about Urogen Pharma Ltd
![](https://www.investors.com/wp-content/uploads/2017/05/IRU4.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/06/18/movers-image_12.jpeg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20240617926085/en/2162885/5/UroGen_logo2_%28R%29.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/06/14/Image45.jpeg?width=1200&height=800&fit=crop)
![](https://www.investors.com/wp-content/uploads/2024/06/Stock-UroGenpharma-01-adobe.jpg)
![](/next-assets/images/schema-image-default.png)
Earnings Outlook For UroGen Pharma
March 13, 2024
Via Benzinga
![](https://mms.businesswire.com/media/20240613476477/en/2158556/5/UroGen_logo2_%28R%29.jpg)
![](https://mms.businesswire.com/media/20240607623862/en/2153485/5/UroGen_logo2_%28R%29.jpg)
![](https://mms.businesswire.com/media/20240606674853/en/2152446/5/UroGen_logo2_%28R%29.jpg)
From UroGen Pharma Ltd.
Via Business Wire
![](https://mms.businesswire.com/media/20240605807048/en/2150777/5/UroGen_logo2_%28R%29.jpg)
![](https://mms.businesswire.com/media/20240603331264/en/2147703/5/UroGen_logo2_%28R%29.jpg)
From UroGen Pharma Ltd.
Via Business Wire
![](https://mms.businesswire.com/media/20240522560591/en/2137738/5/UroGen_logo2_%28R%29.jpg)
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://mms.businesswire.com/media/20240513271801/en/2127663/5/UroGen_logo2_%28R%29.jpg)
![](https://mms.businesswire.com/media/20240507449972/en/2121409/5/UroGen_logo2_%28R%29.jpg)
From UroGen Pharma Ltd.
Via Business Wire
![](https://mms.businesswire.com/media/20240505867534/en/2119735/5/UroGen_logo2_%28R%29_%28002%29.jpg)
![](https://mms.businesswire.com/media/20240504411697/en/2119724/5/UroGen_logo2_%28R%29_%28002%29.jpg)
![](https://mms.businesswire.com/media/20240504905017/en/2119719/5/UroGen_logo2_%28R%29_%28002%29.jpg)
![](https://mms.businesswire.com/media/20240503850056/en/2118123/5/UroGen_logo2_%28R%29.jpg)
![](https://mms.businesswire.com/media/20240417923260/en/2101241/5/UroGen_logo2_%28R%29_%28002%29.jpg)
![](https://mms.businesswire.com/media/20240415706532/en/2097624/5/UroGen_logo2_%28R%29.jpg)
![](https://mms.businesswire.com/media/20240403581964/en/2087347/5/UroGen_logo2_%28R%29.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/03/25/image30.jpeg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://mms.businesswire.com/media/20240314112098/en/2066364/5/UroGen_logo2_%28R%29.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image.jpeg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20240308154847/en/2059165/5/UroGen_logo2_%28R%29.jpg)
![](https://mms.businesswire.com/media/20240304990376/en/2052823/5/UroGen_logo2_%28R%29.jpg)
![](https://mms.businesswire.com/media/20240226631566/en/2043972/5/UroGen_logo2_%28R%29.jpg)
UroGen Pharma to Present at TD Cowen 44th Annual Health Care Conference
February 26, 2024
From UroGen Pharma Ltd.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.